We work hard because you work harder. We build partnerships we can believe in. FAST is pleased to announce that GeneTx Biotherapeutics has been developing a potential ASO treatment for Angelman Syndrome. GeneTx is now partnering with Ultragenyx Pharmaceutical Inc. to ready this therapy for human clinical trials. Read more at Official Press Release #CureAngelman
Latest news
- Parent Blog: Our son, Hudson, is our real life Angel! …by Charlene Cooper21 November 2024 - 2:13 PM
Our son, Hudson, is our real life Angel! Our blue eyed boy was born on 1st December 2020, eager to meet us as he came 3 weeks early. Hudson’s big sisters, Amelia and Madison were delighted with their new role as big sisters to their new little brother, and Daddy (Paul) finally got his […]
- Announcing the Exceptional Winner of Our 2024 Community Member Award9 July 2024 - 11:42 AM
Join Us Today
Join our mailing list to receive the latest updates about research, our projects and fundraising activities.
We never share your data